4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-008779
CVP,Strategy/Corp Development sold 48,900 shares at $103.05 ($5,039,311)
- CVP,Strategy/Corp Development acquired 48,900 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BOBO DONALD E JR · CVP,Strategy/Corp Development
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +48,900 | $72.68 | $3,554,052 | 71,698.25 | D |
| 2026-11-09 | Sale : show line 2 in the form 10b5-1 | −48,900 | $103.05 | $5,039,311 | 22,798.25 | D |
| Open-market sales · 48,900 sh · avg $103.05 · $5,039,311 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-09 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −48,900 | 0 | D |
Loading xslF345X06/doc4.xml…